Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu- positive advanced breast cancer: results of the CECOG LaVie trial.
BMC Cancer
; 16: 121, 2016 Feb 18.
Article
em En
| MEDLINE
| ID: mdl-26887956
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Quinazolinas
/
Vimblastina
/
Neoplasias da Mama
/
Antineoplásicos
Tipo de estudo:
Clinical_trials
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Middle aged
Idioma:
En
Ano de publicação:
2016
Tipo de documento:
Article